Horizon Capital Invests in Viseven, Leading Global Pharma and Life Sciences MarTech Provider
Posted:
Horizon Capital, a U.S. private equity firm investing primarily in fast-growing tech and export-oriented businesses in Ukraine, announced an investment in Viseven, a leading global marketing tech provider servicing the pharma and life sciences industry. This transaction marks the third investment from its latest fund, Horizon Capital Growth Fund IV (HCGF IV), which reached $328 million at its most recent closing held in December 2023.
AI-driven billing for more medically complex inpatient stays has resulted in nearly $1 billion in additional healthcare costs over the last two years, according to new analysis by the Blue Cross Blue Shield Association.
More than 60% of hospitals and…
An artificial intelligence (AI) algorithm increased aneurysm detection, identifying 55 true-positive brain aneurysms that radiologists had missed, representing a 39% relative increase in detection.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us